ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Summary of major clinical studies investigating the efficacy and safety of the subcutaneous implantable cardioverter-defibrillator (S-ICD)

Summary of major clinical studies investigating the efficacy and safety of the subcutaneous implantable cardioverter-defibrillator (S-ICD)
Author (year) Number of patients (n) Appropriate detection rate (%) Inappropriate shock rate (%) Successful conversion with defibrillator function testing (%) Complications requiring intervention (%) Mean follow-up duration (months)
Lambiase et al (2014)[1] 472 NR 7% 99.7% 6.4% 18
Weiss et al (2013)[2] 314 99.8% 14% 100% 1.3% 11
Köbe et al (2013)[3] 69 NR 4% 95.5% 4% 7
Jarman et al (2013)[4] 111 100% 15% 100% 16% 12
Jarman et al (2012)[5] 16 100% 25% 100% 19% 9
Aydin et al (2012)[6] 40 NR 5% 97.5% 13% 8
Olde Nordkamp et al (2012)[7] 118 NR 13% 100% 14% 18
Dabiri et al (2011)[8] 31 100% 16% 100% 10% 9
Bardy et al (2010)[9] 55 100% 9% 98% 11% 10
References:
  1. Lambiase PD, Barr C, Theuns DAMJ, et al. Worldwide experience with a totally subcutaneous implantable defibrillator: early results from the EFFORTLESS S-ICD Registry. Eur Heart J 2014; 35:1657.
  2. Weiss R, Knight BP, Gold MR, et al. Safety and efficacy of a totally subcutaneous implantable-cardioverter defibrillator. Circulation 2013; 128:944.
  3. Köbe J, Reinke F, Meyer C, et al. Implantation and follow-up of totally subcutaneous versus conventional implantable cardioverter-defibrillators: a multicenter case-control study. Heart Rhythm 2013; 10:29.
  4. Jarman JWE, Todd DM. United Kingdom national experience of entirely subcutaneous implantable cardioverter-defibrillator technology: important lessons to learn. Europace 2013; 15:1158.
  5. Jarman JWE, Lascelles K, Wong T, et al. Clinical experience of entirely subcutaneous implantable cardioverter-defibrillators in children and adults: cause for caution. Eur Heart J 2012; 33:1351.
  6. Aydin A, Hartel F, Schlüter M, et al. Shock efficacy of subcutaneous implantable cardioverter-defibrillator for prevention of sudden cardiac death: initial multicenter experience. Circ Arrhythm Electrophysiol 2012; 5:913.
  7. Olde Nordkamp LRA, Dabiri Abkenari L, Boersma LVA, et al. The entirely subcutaneous implantable cardioverter-defibrillator: initial clinical experience in a large Dutch cohort. J Am Coll Cardiol 2012; 60:1933.
  8. Dabiri Abkenari L, Theuns DAMJ, Valk SDA, et al. Clinical experience with a novel subcutaneous implantable defibrillator system in a single center. Clin Res Cardiol 2011; 100:737.
  9. Bardy GH, Smith WM, Hood MA, Crozier IG, Melton IC, Jordaens L, et al. An entirely subcutaneous implantable cardioverter-defibrillator. N Engl J Med 2010; 363:36.
Graphic 97342 Version 1.0

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟